Sense Biodetection

Provider of point of care molecular diagnostics solutions

placeAbingdon, England, United Kingdom calendar_todayFounded 2014 groups43 employees language sense-bio.com

Registered entities

Innovation

18 patent families (7 granted) — focus: Chemistry & metallurgy, Operations & transport; filing pace slowing. Cited 344 times.

YearFilings
20151
20172
20183
20193
202010
20214
20227
20235
20242
20252
20261

Investor mix

29 investors on record; lead investors include Mercia, Koch Disruptive Technologies, Cambridge Innovation Capital, Earlybird.

Investor typeCountShare
Venture capital517%
Other / undisclosed2483%
Coming soon